On ECHEMI
Home > Drugs > Lung cancer
Lung cancer
Lung cancer occurs in the bronchial mucosa or glands, also known as bronchial lung cancer. In the past 50 years, many countries have reported that the incidence of lung cancer has increased significantly. Among male cancer patients, lung cancer has ranked first, and the incidence rate in women has also increased rapidly, accounting for the second or third most common malignant tumors in women. The male-female incidence ratio is 3~5:1, and the age of onset is mostly between 60-79 years old. The cause of lung cancer is still not completely clear. A large amount of data shows that long-term heavy smoking is an important pathogenic factor of lung cancer. For those who smoke more than 40 cigarettes a day for many years, the incidence of squamous cell carcinoma and undifferentiated cancer of the lung is 4 to 10 times higher than that of non-smokers. The incidence of lung cancer in urban residents is higher than that in rural areas, which may be related to air pollution and carcinogens contained in smoke. Therefore, non-smoking should be advocated and urban environmental sanitation work should be strengthened.
Related Drugs
Paclitaxel Injection
Indication: First-line chemotherapy for metastatic ovarian cancer after initial or subsequent chemotherapy failure. Metastatic breast cancer after combined chemotherapy failure or recurrence within 6 months of adjuvant chemotherapy, first-line treatment for advanced non-small cell lung cancer, and adjuvant therapy after surgery for lymph node-positive breast cancer.
Manufacturer:

Shanxi PUDE Pharmaceutical Co., Ltd.

Gefitinib Tablets
Indication: This product is indicated for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) that has previously received chemotherapy.
Gefitinib Tablets
Indication: 1. This product is suitable for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) who have previously received chemotherapy. Previous chemotherapy mainly refers to platinum and docetaxel treatment. 2. The efficacy of this product for patients with locally advanced or metastatic non-small cell lung cancer who have previously received chemotherapy is based on the survival advantage of the preset Asian subgroup in a large-scale placebo-controlled clinical trial (Note: the overall population of this trial did not show improvement in disease-related symptoms and prolonged survival) and the survival data of Chinese non-controlled clinical trials. 3. The results of two large randomized controlled clinical trials showed that gefitinib combined with platinum-containing chemotherapy regimens as the first-line treatment for locally advanced or metastatic NSCLC did not show clinical benefit, so this combination regimen is not recommended.
Sodium norcantharinate injection
Indication: This product can be used for liver cancer, esophageal cancer, stomach and cardia cancer, lung cancer, and leukopenia. It can also be used as a preoperative medication for cancer or in combined chemotherapy.
Sodium norcantharinate injection
Indication: This product can be used for liver cancer, esophageal cancer, stomach and cardia cancer, lung cancer, and leukopenia. It can also be used as a preoperative medication for cancer or in combined chemotherapy.
Manufacturer:

Sinopharm Ronshyn Pharmaceutical Co., Ltd.

Sodium norcantharinate injection
Indication: This product can be used for liver cancer, esophageal cancer, stomach and cardia cancer, lung cancer, and leukopenia. It can also be used as a preoperative medication for cancer or in combined chemotherapy.
Sodium norcantharinate injection
Indication: This product can be used for liver cancer, esophageal cancer, stomach and cardia cancer, lung cancer, and leukopenia. It can also be used as a preoperative medication for cancer or in combined chemotherapy.
Manufacturer:

Tianjin Pharmaceutical Heping (Tianjin) Pharmaceutical Co., Ltd.

Sodium norcantharinate injection
Indication: This product can be used for liver cancer, esophageal cancer, stomach and cardia cancer, lung cancer, and leukopenia. It can also be used as a preoperative medication for cancer or in combined chemotherapy.
Manufacturer:

Chengdu Beite Denuo Pharmaceutical Co., Ltd.

Etoposide
Indication: Mainly for small cell lung cancer, the effective rate increased from 40% to 85%, and the complete remission rate was 14% to 34%. For small cell lung cancer, oral administration is more effective than intravenous injection.
Manufacturer:

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Etoposide
Indication: Mainly for small cell lung cancer, the effective rate increased from 40% to 85%, and the complete remission rate was 14% to 34%. For small cell lung cancer, oral administration is more effective than intravenous injection.
Manufacturer:

Wichita, Its Group of Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.